SCHEMBL18745740

SCHEMBL18745740

CCC(C)(C)c1ccc(NCc2ccccc2)nc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.51
▸ HPGD P15428 3/20 0.51
▸ KDM4E B2RXH2 3/20 0.51
▸ LMNA P02545 2/20 0.51
▸ TP53 P04637 1/20 0.51
▸ SMN1; SMN2 Q16637 4/20 0.50
▸ POLB P06746 1/20 0.50
▸ FABP1 P07148 1/20 0.50
▸ FABP6 P51161 1/20 0.50
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ RAB9A P51151 2/20 0.48
▸ GAA P10253 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ NOS2 P35228 1/20 0.48
▸ NPC1 O15118 2/20 0.46
▸ HDAC4 P56524 1/20 0.44
▸ HDAC6 Q9UBN7 1/20 0.44
▸ CXCR4 P61073 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13657976 0.88 SMN1; SMN2 (0.57) ALDH1A1HPGDKDM4ELMNATP53
SCHEMBL13662122 0.78 FABP1 (0.56) ALDH1A1HPGDKDM4ELMNATP53
SCHEMBL18745854 0.78 HCAR3 (0.51) ALDH1A1HPGDLMNASMN1; SMN2POLB
SCHEMBL19573445 0.77 FABP1 (0.51) ALDH1A1HPGDKDM4ELMNATP53
SCHEMBL22191739 0.76 FABP1 (0.58) ALDH1A1HPGDKDM4ELMNATP53
SCHEMBL11563461 0.76 NOS2 (0.58) ALDH1A1HPGDKDM4ELMNATP53
SCHEMBL10331338 0.74 RAB9A (0.59) ALDH1A1HPGDKDM4ELMNATP53
SCHEMBL13757427 0.74 LMNA (0.54) ALDH1A1HPGDKDM4ELMNASMN1; SMN2
SCHEMBL27652089 0.73 FABP1 (0.54) ALDH1A1HPGDKDM4ELMNATP53
SCHEMBL856048 0.72 VNN1 (0.50) ALDH1A1HPGDKDM4ELMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9624229-B2 Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases RIGEL PHARMACEUTICALS, INC. (US) 2017-04-18 — — US disclosed
Send feedback